Cargando…
A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin
BACKGROUND: Chemodynamic therapy (CDT) relying on intracellular iron ions and H(2)O(2) is a promising therapeutic strategy due to its tumor selectivity, which is limited by the not enough metal ions or H(2)O(2) supply of tumor microenvironment. Herein, we presented an efficient CDT strategy based on...
Autores principales: | Yang, Xiao-Xin, Xu, Xiang, Wang, Mei-Fang, Xu, Hua-Zhen, Peng, Xing-Chun, Han, Ning, Yu, Ting-Ting, Li, Liu-Gen, Li, Qi-Rui, Chen, Xiao, Wen, Yu, Li, Tong-Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107746/ https://www.ncbi.nlm.nih.gov/pubmed/35568865 http://dx.doi.org/10.1186/s12951-022-01455-0 |
Ejemplares similares
-
Dihydroartemisinin-Loaded Magnetic Nanoparticles for Enhanced Chemodynamic Therapy
por: Guo, Shengdi, et al.
Publicado: (2020) -
Dihydroartemisinin remodels macrophage into an M1 phenotype via ferroptosis-mediated DNA damage
por: Li, Liu-Gen, et al.
Publicado: (2022) -
Boosting ferroptosis and microtubule inhibition for antitumor therapy via a carrier-free supermolecule nanoreactor
por: Mu, Min, et al.
Publicado: (2023) -
Injectable Hydrogel for NIR-II Photo-Thermal Tumor Therapy and Dihydroartemisinin-Mediated Chemodynamic Therapy
por: Chen, Danyang, et al.
Publicado: (2020) -
Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy
por: Wang, Xiaoyan, et al.
Publicado: (2021)